Feasibility of combined optical coherence tomography and autofluorescence imaging for visualization of needle biopsy placement.
animal study
autofluorescence
biopsy
lung imaging
optical coherence tomography
Journal
Journal of biomedical optics
ISSN: 1560-2281
Titre abrégé: J Biomed Opt
Pays: United States
ID NLM: 9605853
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
20
03
2020
accepted:
06
10
2020
entrez:
21
10
2020
pubmed:
22
10
2020
medline:
25
9
2021
Statut:
ppublish
Résumé
Diagnosis of suspicious lung nodules requires precise collection of relevant biopsies for histopathological analysis. Using optical coherence tomography and autofluorescence imaging (OCT-AFI) to improve diagnostic yield in parts of the lung inaccessible to larger imaging methods may allow for reducing complications related to the alternative of computed tomography-guided biopsy. Feasibility of OCT-AFI combined with a commercially available lung biopsy needle was demonstrated for visualization of needle puncture sites in airways with diameters as small as 1.9 mm. A miniaturized OCT-AFI imaging stylet was developed to be inserted through an 18G biopsy needle. We present design considerations and procedure development for image-guided biopsy. Ex vivo and in vivo porcine studies were performed to demonstrate the feasibility of the procedure and the device. OCT-AFI scans were obtained ex vivo and in vivo. Discrimination of pullback site is clear. Use of the device is shown to be feasible in vivo. Images obtained show the stylet is effective at providing structural information at the puncture site that can be used to assess the diagnostic potential of the sample prior to collection.
Identifiants
pubmed: 33084256
pii: JBO-200078RR
doi: 10.1117/1.JBO.25.10.106003
pmc: PMC7573340
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : R43 CA203033
Pays : United States
Références
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
Chest. 2013 Oct;144(4):1261-1268
pubmed: 23828441
Biomed Opt Express. 2012 Aug 1;3(8):1947-54
pubmed: 22876357
Chest. 2011 Dec;140(6):1669-1670
pubmed: 22147832
Lasers Surg Med. 1991;11(2):99-105
pubmed: 2034016
Ann Am Thorac Soc. 2015 Feb;12(2):193-201
pubmed: 25562183
Chest. 2010 Oct;138(4):984-8
pubmed: 20472863
Chest. 1999 Jul;116(1):139-43
pubmed: 10424517
Lung Cancer. 2005 Sep;49(3):387-94
pubmed: 15922488
Am J Respir Cell Mol Biol. 2014 Sep;51(3):334-43
pubmed: 24828366
J Bronchology Interv Pulmonol. 2018 Jul;25(3):189-197
pubmed: 29659420
BMC Cancer. 2013 Mar 19;13:130
pubmed: 23510132
Acta Radiol. 2008 Oct;49(8):876-82
pubmed: 18618301
J Laryngol Otol. 1999 Feb;113(2):149-51
pubmed: 10396565
Opt Lett. 2011 Oct 1;36(19):3894-6
pubmed: 21964133
Eur Respir J. 2011 Apr;37(4):902-10
pubmed: 20693253
Opt Lett. 2016 Jul 15;41(14):3209-12
pubmed: 27420497
Oncologist. 2001;6(3):257-62
pubmed: 11423672
Opt Lett. 2003 Nov 1;28(21):2067-9
pubmed: 14587817
N Engl J Med. 2020 Feb 6;382(6):503-513
pubmed: 31995683
Ann Am Thorac Soc. 2019 Nov;16(11):1360-1362
pubmed: 31437410
Clin Cancer Res. 2008 Apr 1;14(7):2006-11
pubmed: 18381938
Am J Respir Crit Care Med. 2013 Apr 15;187(8):848-54
pubmed: 23348977
Thorax. 2005 Jun;60(6):496-503
pubmed: 15923251
Chest. 2020 Apr;157(4):994-1011
pubmed: 31738928
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
J Bronchology Interv Pulmonol. 2020 Apr;27(2):106-121
pubmed: 31985505
Respiration. 2010;79(2):137-40
pubmed: 19707013
Nat Med. 1995 Sep;1(9):970-2
pubmed: 7585229